Lung Cancer Trial, Not Yet Recruiting NCT06202690 Sponsor: Korea University Guro Hospital Condition: Lung Cancer
Back to Lung Cancer

Lung Cancer Trial, Not Yet Recruiting

NCT06202690
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who are scheduled to have part of a lung removed (a segment or a lobe) using keyhole-style surgery for non-small cell lung cancer or a suspected cancerous growth.
  • People aged 18 or older.
  • People who are able to follow the requirements of the trial and who, or their legal guardian, have given written agreement to participate before the trial begins.
  • People who are South Korean nationals.
  • People whose general health before surgery has been rated as level 1, 2, or 3 on a standard medical fitness scale used by anaesthetists (confirm with trial site).
  • People diagnosed with non-small cell lung cancer at clinical stage I, II, or IIIa.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who need surgery on another organ at the same time.
  • People whose cancer has grown into the chest wall, the diaphragm, or another lobe of the lung.
  • People whom the research team considers unsuitable for the trial for any reason.
  • People with cognitive difficulties that prevent them from understanding the study instructions or consent process.
  • People who have a strong preference for a specific type of surgery (such as robotic, keyhole, or open chest surgery).
  • People who have previously had chest surgery on the same side of the chest being operated on.
  • People whose test results show a condition other than non-small cell lung cancer, such as a non-cancerous growth, cancer that has spread from elsewhere in the body, or a different type of lung cancer called small cell lung cancer.
  • People who have already received pre-surgery cancer treatment (such as chemotherapy or radiation) before the operation.
  • People whose planned surgery involves removing an entire lung, two lobes, a lobe plus a segment, or a non-precise removal such as a wedge resection.
  • People who have been diagnosed with another type of cancer within the past 5 years.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 29 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 01072579550

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Korea University Guro Hospital
Registry
ClinicalTrials.gov
Start date
9 January 2024
Est. completion
30 June 2026

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Primary endpoints

Postoperative complications; Questionnaires for HRQOL of life (EQ-5D-5L) at month 3; Questionnaires for HRQOL of life (EQ-VAS) at month 3; Postoperative pain

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 29 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov